Dalteparin
Showing 1 - 25 of 264
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)
Recruiting
- Anticoagulant
- +3 more
- Dalteparin Prefilled Syringe
- Tinzaparin profiled syringe
-
Copenhagen, Denmark
- +8 more
Aug 29, 2023
Hepatic Disease, Surgery-Complications, Hypercoagulability Trial in London (Redesca (enoxaparin sodium for injection), Fragmin
Not yet recruiting
- Hepatic Disease
- +3 more
- Redesca (enoxaparin sodium for injection)
- Fragmin (dalteparin)
-
London, Ontario, CanadaLondon Health Sciences Centre
Nov 22, 2023
Venous Thromboembolism, Varicose Veins Trial in London (Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium)
Not yet recruiting
- Venous Thromboembolism
- Varicose Veins
- Dalteparin Sodium
- +5 more
-
London, United KingdomImperial College Hospital NHS Foundation Trust
Feb 20, 2023
Nephrotic Syndrome, Thromboembolic Disease Trial in Aarhus (Dalteparin, Apixaban)
Recruiting
- Nephrotic Syndrome
- Thromboembolic Disease
- Dalteparin
- Apixaban
-
Aarhus, DenmarkAarhus University Hospital
May 20, 2022
Cancer-associated Thrombosis, Thrombocytopenia Trial (Enoxaparin, Dalteparin, Tinzaparin)
Not yet recruiting
- Cancer-associated Thrombosis
- Thrombocytopenia
- Enoxaparin
- +2 more
- (no location specified)
Apr 19, 2022
Pancreas Cancer, Pancreas Tumor, Surgery Trial (enoxaparin/tinzaparin/dalteparin)
Not yet recruiting
- Pancreas Cancer
- +4 more
- (no location specified)
Feb 8, 2022
Liver Cancer, Surgery, Thrombosis, Deep Vein Trial in Finland, Norway (enoxaparin or tinzaparin or dalteparin, No intervention)
Recruiting
- Liver Cancer
- +4 more
- enoxaparin or tinzaparin or dalteparin
- No intervention
-
Helsinki, Finland
- +5 more
Sep 21, 2022
Bone Sarcoma, Femur Fracture, Lymphoma Trial in Houston (Dalteparin)
Completed
- Bone Sarcoma
- +6 more
- Dalteparin
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2020
Deep Venous Thrombosis, Pulmonary Embolism Trial in Worldwide (Low dose nadroparin, Intermediate dose nadroparin, Low dose
Completed
- Deep Venous Thrombosis
- Pulmonary Embolism
- Low dose nadroparin
- +7 more
-
New York, New York
- +71 more
May 21, 2022
Cancer, Venous Thromboembolism, Obesity Trial in Canada (Dalteparin)
Recruiting
- Cancer
- +2 more
- Dalteparin
-
Edmonton, Alberta, Canada
- +4 more
Jan 12, 2021
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
Kidney Failure Trial in London (Dalteparin)
Completed
- Kidney Failure
- Dalteparin
-
London, Ontario, CanadaLondon Health Sciences Centre
Feb 20, 2020
Dosing of Thromboprophylaxis and Mortality in Critically Ill
Completed
- Covid19
- Thromboembolism
- Dose of tinzaparin or dalteparin
-
Stockholm, SwedenSödersjukhuset
Oct 18, 2020
Venous Thromboembolism Trial in Russian Federation (Dimolegin 40 mg, Dimolegin 60 mg, Fragmin)
Active, not recruiting
- Venous Thromboembolism
- Dimolegin 40 mg
- +2 more
-
Bryansk, Russian Federation
- +14 more
Apr 25, 2022
Cervical Cancer, Chronic Myeloproliferative Disorders, Leukemia Trial in Los Angeles (Fragmin, )
Completed
- Cervical Cancer
- +8 more
- Fragmin
- placebo
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
Cancer-associated Thrombosis, Esophageal Cancer, Stomach Cancer Trial in Seoul (Rivaroxaban, Dalteparin, apixaban)
Unknown status
- Cancer-associated Thrombosis
- +9 more
- Rivaroxaban
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 2, 2020
Cerebral Vein Thrombosis, Deep Vein Thrombosis, Gonadal Thrombosis Trial in United States (Apixaban, Dalteparin, Questionnaire
Completed
- Cerebral Vein Thrombosis
- +11 more
- Apixaban
- +2 more
-
Scottsdale, Arizona
- +17 more
Jul 31, 2020
28-days Mortality in Critically Ill COVID-19 Patients
Completed
- Covid-19
- +2 more
- Dose of Tinzaparin or Dalteparin
-
Stockholm, Stockholms Län, SwedenSouth General Hospital
Jun 18, 2020
Acute DVT of Lower Extremity Trial in Rochester (Vascular Boot, Standard of Care)
Terminated
- Acute DVT of Lower Extremity
- Vascular Boot
- Standard of Care
-
Rochester, MinnesotaMayo Clinic
Jul 30, 2020
Vasopressors on Anti-Xa Activity in Critically Ill Patients
Recruiting
- Critical Illness
- Thrombosis
- Serum anti-Xa activity
-
Gdańsk, PolandMedical University of Gdańsk - Departament of Anesthesiology and
Sep 20, 2023
Antiphospholipid Syndrome in Pregnancy, Pregnancy Loss Trial in Ottawa (Aspirin 81 mg, Low-molecular-weight heparin)
Terminated
- Antiphospholipid Syndrome in Pregnancy
- Pregnancy Loss
- Aspirin 81 mg
- Low-molecular-weight heparin
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Mar 25, 2020
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022